Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Nakano

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
BMJ Open|November 21, 2022
Adoptive immunotherapy with natural killer cells from peripheral blood CD34<sup>+</sup> stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I studyMasahiro Ohira, Tsuyoshi Kobayashi, Yuka Tanaka, et al.
Frontiers in Oncology|June 16, 2023
IL-22BP controls the progression of liver metastasis in colorectal cancerAnastasios D Giannou, Jan Kempski, Tao Zhang, et al.
Oncoimmunology|October 25, 2023
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesisTao Zhang, Ramez Wahib, Dimitra E Zazara, et al.
Current Problems in Surgery|December 7, 2025
Transforming orthotopic liver transplantation: Innovative dry-lab simulation model in miceAnas Amin Preukschas, Rainer Grotelüschen, Ryosuke Nakano, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
BMJ Open|November 21, 2022
Adoptive immunotherapy with natural killer cells from peripheral blood CD34<sup>+</sup> stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I studyMasahiro Ohira, Tsuyoshi Kobayashi, Yuka Tanaka, et al.
Frontiers in Oncology|June 16, 2023
IL-22BP controls the progression of liver metastasis in colorectal cancerAnastasios D Giannou, Jan Kempski, Tao Zhang, et al.
Oncoimmunology|October 25, 2023
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesisTao Zhang, Ramez Wahib, Dimitra E Zazara, et al.
Current Problems in Surgery|December 7, 2025
Transforming orthotopic liver transplantation: Innovative dry-lab simulation model in miceAnas Amin Preukschas, Rainer Grotelüschen, Ryosuke Nakano, et al.
Pageof 10